EUVIMEDEUVIMED entdecken
StudienprotokollOpen Access · CC BY 4.0

BIO3 Protocol: Clinical and In Vitro Evidence of Triple Biostimulation With CaHA and P ( LA / CL ) Threads

Luiz Tonon iD, Maria Oneide Alves, Renata Viana

Journal of Cosmetic Dermatology · 2026

DOI: 10.1111/jocd.70803 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift Journal of Cosmetic Dermatology, 2026. Verfasst von Luiz Tonon und 2 weiteren Autor:innen. Beteiligte Einrichtung: Private Practice, São Paulo, Brazil. Hauptthemen laut MEDLINE: Skin Aging, Durapatite, Cosmetic Techniques, Absorbable Implants. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Facial aging involves progressive deterioration of the extracellular matrix (ECM), volume loss, and structural sagging. Minimally invasive strategies like absorbable threads provide mechanical support and biostimulation, but their efficacy may be compromised in patients with poor dermal quality. Calcium Hydroxyapatite (CaHA) is a well‐documented biostimulator that enhances collagen and elastin synthesis. This study explored whether combining CaHA with P (LA/CL)‐based absorbable threads could synergistically improve ECM remodeling and clinical outcomes.

Aims

To evaluate the biological and clinical effects of the BIO3 protocol—sequential biostimulation with CaHA and P (LA/CL) threads—by integrating in vitro gene expression analysis and retrospectively collected clinical outcomes. Patients/Methods An in vitro model of full‐thickness human skin was used to assess COL1A1 , COL3A1 , and ELN expression after treatment with CaHA, P (LA/CL) threads, or both. A retrospective clinical study was also conducted with 11 female patients aged 35–65 undergoing facial rejuvenation with threads alone ( n = 6) or preceded by CaHA ( n = 5). Clinical outcomes were assessed using GAIS, WSRS, facial laxity scores, ultrasound imaging, and satisfaction questionnaires at multiple timepoints.

Results

Combined in vitro treatment resulted in significantly higher upregulation of ECM‐related genes compared to monotherapies. Clinically, all patients showed aesthetic improvement. The CaHA/P (LA/CL) group demonstrated greater dermal and subcutaneous thickening and higher GAIS ratings at D120. Patient satisfaction reached 100% in both groups by D30 and remained stable. No adverse events were reported.

Conclusions

The BIO3 protocol—combining CaHA and P (LA/CL) threads—showed promising synergistic effects on ECM remodeling and aesthetic outcomes. These findings support the rationale for layered and sequential biostimulation strategies in clinical practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Skin AgingDurapatiteCosmetic TechniquesAbsorbable ImplantsHumansFemaleAdultMiddle AgedRetrospective StudiesAgedCollagen Type IRejuvenationCollagen Type IIIPatient SatisfactionFaceElastinCollagen Type I, alpha 1 ChainExtracellular MatrixSkinTreatment Outcome

Substanzen

DurapatiteCollagen Type ICollagen Type IIIElastinCollagen Type I, alpha 1 ChainCOL3A1 protein, human

Autor:innen und Institutionen

  • Private Practice, São Paulo, Brazil.
  • Ilikia Brasil, São Paulo, Brazil.

ORCID-Profile: Luiz Tonon

Zitieren

APA

Tonon, L., Alves, M. O., & Viana, R. (2026). BIO3 Protocol: Clinical and In Vitro Evidence of Triple Biostimulation With CaHA and P ( LA / CL ) Threads. Journal of Cosmetic Dermatology. https://doi.org/10.1111/jocd.70803

Vancouver

Tonon L, Alves MO, Viana R. BIO3 Protocol: Clinical and In Vitro Evidence of Triple Biostimulation With CaHA and P ( LA / CL ) Threads. Journal of Cosmetic Dermatology. 2026. doi:10.1111/jocd.70803

BibTeX
@article{Tonon2026,
  author = {Tonon, Luiz and Alves, Maria Oneide and Viana, Renata},
  title = {BIO3 Protocol: Clinical and In Vitro Evidence of Triple Biostimulation With CaHA and P ( LA / CL ) Threads},
  journal = {Journal of Cosmetic Dermatology},
  year = {2026},
  doi = {10.1111/jocd.70803}
}
Kostenlos starten →